|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in the Production of Th2 Subpopulations: Implications for Variable Th2-Mediated Pathologies in Autoimmunity1
,


*
Division of Molecular Pathogenesis, Skirball Institute of Biomolecular Medicine, and
Department of Pathology and
Sackler Institute of Graduate Biomedical Sciences, New York University Medical Center, New York, NY 10016
It has become increasingly apparent in studies of mutant mice and
observations of disease that cytokine production by fully committed
effector T cells within the Th1 and Th2 phenotype can vary within each
group. This can potentially influence the type and effectiveness of a
given immune response. The factors responsible for inducing variable
Th1 and Th2 subtype responses have not been well established. Using
transgenic mice expressing the myelin basic protein-specific TCR, we
demonstrate here that two distinct populations of Th2 cells that are
characterized primarily by differential IL-4 and IL-5 expression levels
can be generated depending upon the levels of IFN-
present at the
time of priming. We also demonstrate that populations expressing high
levels of IL-4 relative to IL-5 vs those with intermediate levels of
IL-4 relative to IL-5 are stable and possess distinct effector
functions in an experimental autoimmune encephalomyelitis
model.
This article has been cited by other articles:
![]() |
A. K. Wensky, G. C. Furtado, M. C. Garibaldi Marcondes, S. Chen, D. Manfra, S. A. Lira, D. Zagzag, and J. J. Lafaille IFN-{gamma} Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis J. Immunol., February 1, 2005; 174(3): 1416 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abromson-Leeman, R. Bronson, Y. Luo, M. Berman, R. Leeman, J. Leeman, and M. Dorf T-Cell Properties Determine Disease Site, Clinical Presentation, and Cellular Pathology of Experimental Autoimmune Encephalomyelitis Am. J. Pathol., November 1, 2004; 165(5): 1519 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bocek Jr., G. Foucras, and W. E. Paul Interferon {gamma} Enhances Both In Vitro and In Vivo Priming of CD4+ T Cells for IL-4 Production J. Exp. Med., June 21, 2004; 199(12): 1619 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weir, C. C. A. Bernard, and B. T. Backstrom IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis Int. Immunol., November 1, 2003; 15(11): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Jansson, J Ernerudh, M Kvarnstrom, C Ekerfelt, and M Vrethem Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-b1a or glatiramer acetate compared with untreated patients Multiple Sclerosis, October 1, 2003; 9(5): 440 - 445. [Abstract] [PDF] |
||||
![]() |
M. P. Mycko, R. Papoian, U. Boschert, C. S. Raine, and K. W. Selmaj cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity Brain, May 1, 2003; 126(5): 1048 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Hill, K. Van Gunst, and N. Sarvetnick Th1 and Th2 Pancreatic Inflammation Differentially Affects Homing of Islet-Reactive CD4 Cells in Nonobese Diabetic Mice J. Immunol., February 15, 2003; 170(4): 1649 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schramm, U. Herz, J. Podlech, M. Protschka, S. Finotto, M. J. Reddehase, H. Kohler, P. R. Galle, A. W. Lohse, and M. Blessing TGF-{beta} Regulates Airway Responses Via T Cells J. Immunol., February 1, 2003; 170(3): 1313 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Fukushima, K Fukata, A Ozaki, M Takata, N Kuroda, H Enzan, and H Ueno Exertion of the suppressive effects of IFN-{gamma} on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase Br J Ophthalmol, October 1, 2002; 86(10): 1166 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nicolson, S. Freland, C. Weir, B. Delahunt, R. A. Flavell, and B. T. Backstrom Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2 Int. Immunol., August 1, 2002; 14(8): 849 - 856. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |